Sandoz, Inc. (“Sandoz”) entered into the battlefield over patents related to AbbVie’s Humira® (adalimumab). On July 20, 2017,...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
Invalidity
-
-
Samsung Bioepsis UK Limited (“Samsung”), Biogen Idec Limited (“Biogen”), and Fujifilm Kyowa Kirin Biologic Company Limited...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Coherus Biosciences, Inc. (“Coherus”) has filed four petitions with the Patent Trial and Appeal Board (“PTAB”) for inter partes...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]